US Broker Ratings

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Potential Upside of Over 81% in the Rare Disease Sector

For investors with a keen eye on the healthcare sector, Eton Pharmaceuticals, Inc. (NASDAQ: ETON) presents a compelling opportunity to explore. Specializing in the development and..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring a 50% Upside Potential Amidst Strong Buy Ratings

AnaptysBio, Inc. (NASDAQ: ANAB) is catching the attention of investors with its intriguing mix of a strong analyst buy consensus and significant upside potential. As a..

InMode Ltd. (INMD) Stock Analysis: Unpacking the 16.41% Potential Upside in the Medical Device Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, has been making waves with its innovative aesthetic medical..

Phibro Animal Health Corporation (PAHC) Stock Report: Exploring Growth with a 39.7% Revenue Surge

Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector specializing in drug manufacturing for animals, has been making waves with its impressive..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a Complex Healthcare Landscape with 15.1% Revenue Growth

InnovAge Holding Corp. (NASDAQ: INNV) is carving out a niche in the competitive healthcare sector, focusing on providing comprehensive care for seniors through its Program of..

AMN Healthcare Services Inc (AMN) Stock Analysis: Evaluating the 30% Potential Upside in Healthcare Staffing

AMN Healthcare Services Inc (NYSE: AMN) stands as a dynamic entity in the healthcare sector, providing comprehensive workforce solutions and staffing services across the United States...

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Strong Buy Ratings Amid Impressive Revenue Growth and Promising Pipeline

Investors keen on the healthcare sector, particularly biotechnology, may find Stoke Therapeutics, Inc. (NASDAQ: STOK) a compelling addition to their portfolios. With a market capitalization of..

Savara, Inc. (SVRA) Stock Analysis: A Promising Biotech with an 87% Potential Upside

Investors are turning their attention towards Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases. With its market capitalization standing at $1.17..

GH Research PLC (GHRS) Stock Analysis: 109.70% Upside Potential Amid Promising Biotech Innovations

Investors with an eye on the biotechnology sector may find GH Research PLC (NASDAQ: GHRS) a particularly intriguing opportunity. Based in Dublin, Ireland, this clinical-stage biopharmaceutical..

Capricor Therapeutics, Inc. (CAPR) Investor Outlook: Biotechnology Giant Poised for Nearly 99% Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology firm based in San Diego, California, is capturing investor attention with its promising advancements in cell and exosome-based..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Navigating High Potential with a 21.88% Upside in Biotechnology

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is garnering attention from investors due to its promising developments in the biotechnology sector. Specializing in novel..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Riding the Wave of Healthcare Innovation with 9.68% Upside Potential

Castle Biosciences, Inc. (NASDAQ: CSTL) is carving a niche in the healthcare sector with its innovative diagnostic solutions, offering investors a compelling opportunity to tap into..

Replimune Group, Inc. (REPL) Stock Analysis: Exploring a 52.75% Upside Potential in Biotech

Replimune Group, Inc. (NASDAQ: REPL) is drawing significant attention from investors intrigued by its innovative approach to cancer treatment and potential for substantial stock appreciation. As..

Semler Scientific, Inc. (SMLR) Stock Analysis: Unveiling a 217% Potential Upside Amidst Market Challenges

Investors looking for promising opportunities in the healthcare sector may find Semler Scientific, Inc. (NASDAQ: SMLR) an intriguing option. Specializing in medical devices, Semler Scientific provides..

Neuropace, Inc. (NPCE) Investor Outlook: Exploring the 13.5% Potential Upside in Medical Devices

In the rapidly evolving field of medical devices, Neuropace, Inc. (NASDAQ: NPCE) stands out with its cutting-edge solutions for treating drug-resistant focal epilepsy. With a market..

Enhabit, Inc. (EHAB) Stock Analysis: Evaluating Growth Potential with a 4.02% Upside

Enhabit, Inc. (EHAB), a prominent player in the healthcare sector, operates within the medical care facilities industry, providing essential home health and hospice services across the..

Arvinas, Inc. (ARVN) Stock Analysis: Examining the Biotech’s Potential with Recent Analyst Ratings

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology firm, is navigating the complex landscape of drug development with a focus on innovative therapies aimed at degrading disease-causing..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: Innovative Biotech with 86.51% Upside Potential

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a dynamic player in the biotechnology sector, is attracting significant attention from investors, thanks to its promising pipeline and substantial potential..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a Potential 245% Upside in the Biotechnology Sector

Investors with a keen eye on the biotechnology sector may find LENZ Therapeutics, Inc. (NASDAQ: LENZ) a compelling opportunity, particularly given its massive potential upside of..

Sana Biotechnology, Inc. (SANA)

⚠️ No article content returned.

..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds